New Research on BV and a Possible Link to Chlamydia

A new study found that there are two distinct types of BV infection, one of which increases the risk of chlamydia infection.
Two Studies Show Doxy PEP is a Winning Strategy

Two studies published in this month’s JAMA Internal Medicine offer encouraging findings about the use of Doxy PEP.
NGU, or Nongonoccocal Urethritis

Nongonococcal urethritis—or NGU—is an infection of the urethra caused by germs other than gonorrhea. The most common cause is chlamydia.
New CDC Guidelines Offer Recommendations On Doxy PEP

Doxy PEP involves taking an oral antibiotic after condomless sex to prevent bacterial STIs. Research has shown that this can reduce the possibility of contracting chlamydia by 88%, syphilis by 87%, and gonorrhea by 55%.
An Experimental Vaccine for Chlamydia Shows Promise in Early Study

A Phase 1 trail for a possible new chlamydia vaccine had encouraging results. Chlamydia is one of the most common STIs worldwide—a vaccine could dramatically change this landscape.
Doxy PEP is a New Strategy to Help Prevent STIs

Doxy PEP is the strategy of taking the antibiotic doxycycline after condomless oral or anal sex to prevent chlamydia, gonorrhea, or syphilis.
New Studies Add to Evidence that Doxy PEP Works for STI Prevention

New studies add to our evidence that doxy PEP is working to prevent bacterial STIs among transgender women and men who have sex with men.
PID is a leading cause of infertility in women

Pelvic Inflammatory Disease (PID) Pelvic inflammatory disease (PID) is a serious infection in the upper genital tract/reproductive organs (uterus, fallopian tubes and ovaries) of women. PID can be sexually transmitted or naturally occurring. It can lead to infertility in women (unable to have children) or life-threatening complications. Women between ages 15 and 25 have the […]
The State of STIs — CDC Reports an Alarming Rise in Syphilis

CDC released new surveillance data on sexually transmitted infections. There were 2.5 million cases of chlamydia, gonorrhea, and syphilis reported in the United States in 2022. Rates of gonorrhea and chlamydia remain high, and rates of syphilis have gone up an alarming 80% since 2018.
Improving Chlamydia Screening Rates Through Opt-Out Screening

Jointly provided by Postgraduate Institute for Medicine and American Sexual Health Association. This activity is supported by an independent educational grant from Hologic.